HomeComparePSTTF vs GIS

PSTTF vs GIS: Dividend Comparison 2026

PSTTF yields 1379.31% · GIS yields 6.55%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PSTTF wins by $327926178.86M in total portfolio value
10 years
PSTTF
PSTTF
● Live price
1379.31%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$327926178.94M
Annual income
$286,995,341,463,684.70
Full PSTTF calculator →
GIS
GIS
● Live price
6.55%
Share price
$37.11
Annual div
$2.43
5Y div CAGR
22.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$79.2K
Annual income
$16,311.42
Full GIS calculator →

Portfolio growth — PSTTF vs GIS

📍 PSTTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPSTTFGIS
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PSTTF + GIS cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PSTTF pays
GIS pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PSTTF
Annual income on $10K today (after 15% tax)
$117,241.38/yr
After 10yr DRIP, annual income (after tax)
$243,946,040,244,131.97/yr
GIS
Annual income on $10K today (after 15% tax)
$556.59/yr
After 10yr DRIP, annual income (after tax)
$13,864.71/yr
At 15% tax rate, PSTTF beats the other by $243,946,040,230,267.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PSTTF + GIS for your $10,000?

PSTTF: 50%GIS: 50%
100% GIS50/50100% PSTTF
Portfolio after 10yr
$163963089.51M
Annual income
$143,497,670,739,998.06/yr
Blended yield
87.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GIS right now

PSTTF
No analyst data
GIS
Analyst Ratings
9
Buy
19
Hold
6
Sell
Consensus: Hold
Price Target
$47.42
+27.8% upside vs current
Range: $35.00 — $63.00
Altman Z
2.2
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PSTTF buys
0
GIS buys
0
No recent congressional trades found for PSTTF or GIS in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPSTTFGIS
Forward yield1379.31%6.55%
Annual dividend / share$2.00$2.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.8%
Portfolio after 10y$327926178.94M$79.2K
Annual income after 10y$286,995,341,463,684.70$16,311.42
Total dividends collected$324920394.51M$51.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: PSTTF vs GIS ($10,000, DRIP)

YearPSTTF PortfolioPSTTF Income/yrGIS PortfolioGIS Income/yrGap
1← crossover$148,631$137,931.03$11,504$804.11+$137.1KPSTTF
2$2,075,001$1,915,965.64$13,371$1,061.65+$2.06MPSTTF
3$27,218,680$24,998,428.97$15,723$1,416.15+$27.20MPSTTF
4$335,586,754$306,462,766.83$18,735$1,911.16+$335.57MPSTTF
5$3,890,354,077$3,531,276,249.42$22,660$2,613.51+$3890.33MPSTTF
6$42,421,557,343$38,258,878,480.81$27,874$3,627.81+$42421.53MPSTTF
7$435,284,512,667$389,893,446,310.20$34,947$5,121.52+$435284.48MPSTTF
8$4,204,696,744,549$3,738,942,315,995.26$44,762$7,369.21+$4204696.70MPSTTF
9$38,253,119,134,080$33,754,093,617,412.28$58,728$10,832.80+$38253119.08MPSTTF
10$327,926,178,937,150$286,995,341,463,684.70$79,151$16,311.42+$327926178.86MPSTTF

PSTTF vs GIS: Complete Analysis 2026

PSTTFStock

Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase 2a clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. It has a strategic collaboration with The University of Texas MD Anderson Cancer Center to develop blood cancer binder for OmniCAR. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.

Full PSTTF Calculator →

GISConsumer Staples

General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates in five segments: North America Retail; Convenience Stores & Foodservice; Europe & Australia; Asia & Latin America; and Pet. It offers ready-to-eat cereals, refrigerated yogurt, soup, meal kits, refrigerated and frozen dough products, dessert and baking mixes, bakery flour, frozen pizza and pizza snacks, snack bars, fruit and salty snacks, ice cream, nutrition bars, wellness beverages, and savory and grain snacks, as well as various organic products, including frozen and shelf-stable vegetables. It also supplies branded and unbranded food products to the North American foodservice and commercial baking industries; and manufactures and markets pet food products, including dog and cat food. The company markets its products under the Annie's, Betty Crocker, Bisquick, Blue Buffalo, Blue Basics, Blue Freedom, Bugles, Cascadian Farm, Cheerios, Chex, Cinnamon Toast Crunch, Cocoa Puffs, Cookie Crisp, EPIC, Fiber One, Food Should Taste Good, Fruit by the Foot, Fruit Gushers, Fruit Roll-Ups, Gardetto's, Go-Gurt, Gold Medal, Golden Grahams, Häagen-Dazs, Helpers, Jus-Rol, Kitano, Kix, Lärabar, Latina, Liberté, Lucky Charms, Muir Glen, Nature Valley, Oatmeal Crisp, Old El Paso, Oui, Pillsbury, Progresso, Raisin Nut Bran, Total, Totino's, Trix, Wanchai Ferry, Wheaties, Wilderness, Yoki, and Yoplait trademarks. It sells its products directly, as well as through broker and distribution arrangements to grocery stores, mass merchandisers, membership stores, natural food chains, e-commerce retailers, commercial and noncommercial foodservice distributors and operators, restaurants, convenience stores, and pet specialty stores, as well as drug, dollar, and discount chains. The company operates 466 leased and 392 franchise ice cream parlors. General Mills, Inc. was founded in 1866 and is headquartered in Minneapolis, Minnesota.

Full GIS Calculator →
📬

Get this PSTTF vs GIS comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PSTTF vs SCHDPSTTF vs JEPIPSTTF vs OPSTTF vs KOPSTTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.